Cargando…
The NeST (neoadjuvant systemic therapy in breast cancer) study – Protocol for a prospective multi-centre cohort study to assess the current utilization and short-term outcomes of neoadjuvant systemic therapies in breast cancer
INTRODUCTION: Neoadjuvant systemic therapy (NST) has several potential advantages in the treatment of breast cancer. However, there is currently considerable variation in NST use across the UK. The NeST study is a national, prospective, multicentre cohort study that will investigate current patterns...
Autores principales: | Irwin, G.W., Bannon, F., Coles, C.E., Copson, E., Cutress, R.I., Dave, R.V., Grayson, M., Holcombe, C., Irshad, S., O'Brien, C., O'Connell, R.L., Palmieri, C., Shaaban, A.M., Sharma, N., Singh, J., Whitehead, I., Potter, S., McIntosh, S.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921204/ https://www.ncbi.nlm.nih.gov/pubmed/31897446 http://dx.doi.org/10.1016/j.isjp.2019.10.002 |
Ejemplares similares
-
The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision making
por: Whitehead, I., et al.
Publicado: (2021) -
Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study
por: Fatayer, Hiba, et al.
Publicado: (2022) -
Corrigendum to: Current practice and surgical outcomes of neoadjuvant chemotherapy for early breast cancer: UK NeST study
por: Fatayer, Hiba, et al.
Publicado: (2022) -
Neoadjuvant systemic therapy for breast cancer
por: Zaborowski, Alexandra M, et al.
Publicado: (2023) -
Assesssment of the effect of pretreatment with neoadjuvant therapy on primary breast cancer.
por: Gazet, J. C., et al.
Publicado: (1996)